Rocket Lab’s Neutron Timeline and SpaceX Contagion Compound a 58% Slide
Published on 07/26/2026 at 04:12 | Redaktion boerse-global.de
The sell-off in Rocket Lab shares is no longer a single-story affair. On Friday, the stock dropped 8.29 percent to €56.40, extending a decline that has now erased 57.85 percent from the May high. But what looks at first glance like a routine pullback in a high-beta name is actually the collision of two distinct pressures: a sector-wide downdraft triggered by SpaceX and a deepening credibility gap around the company’s own Neutron rocket program.
A Sympathy Move With an Edge
Friday’s catalyst came from outside Rocket Lab’s walls. SpaceX shares fell five percent ahead of the 13th test flight of its Starship program, as investors fretted over the mounting costs and execution risks of diverting resources from the proven Falcon 9 line. Reports that SpaceX may stop offering dedicated Falcon 9 launches for external satellite operators by 2028 added to the unease. The sell-off rippled across the space sector, dragging down Intuitive Machines and AST SpaceMobile alongside Rocket Lab — none of which had reported company-specific news that day.
Yet this sympathy move landed on ground already softened by Rocket Lab’s own challenges. The stock now trades 36.67 percent below its 50-day moving average of €89.05 and 16.27 percent below the 200-day line at €67.36. The 14-day relative strength index sits at 30.8, flirting with oversold territory. The annualized 30-day volatility of 88.21 percent underscores how tightly the shares are tethered to a single variable: the next update on Neutron.
Neutron’s Slippery Schedule
The medium-lift rocket was originally slated to fly by the end of 2025. That target slipped to the first quarter of 2026, then to the fourth quarter — the second delay in just over a year. Each postponement chips away at management’s credibility, even as CEO Peter Beck frames the caution as diligence rather than dysfunction. Beck has pointed to the placement of hardware on test stands as the true measure of progress, and a recent full-duration burn test of Neutron’s second stage did mark a genuine milestone. Still, the program has been rocky: components originally destined for flight were lost earlier this year during testing.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The stakes could hardly be higher. Rocket Lab is in the middle of a strategic reinvention, pivoting from a small-satellite launcher to a vertically integrated defense, communications, and reusable-rocket provider. The planned $8 billion acquisition of Iridium Communications is a central piece of that vision, but it also fuels concerns about dilution, higher leverage, and integration risk. The entire thesis — and the premium valuation that goes with it — depends on Neutron flying reliably.
Meanwhile, competition is closing in. Northrop Grumman is working with Firefly Aerospace on a medium-lift rocket called Eclipse that could fly as early as next year, offering customers a credible alternative to both SpaceX and Rocket Lab. Some of the customers who have already signed launch contracts with Neutron may start looking elsewhere if the timeline slips again.
A Valuation That Defies the Chart
Despite the brutal price action, Wall Street remains broadly constructive. Rocket Lab carries a “Strong Buy” consensus rating on TipRanks, with a median price target of €100.50 — implying roughly 78 percent upside from current levels. Morgan Stanley analyst Kristine Liwag maintains a “Buy” rating and sees meaningful upside. The company’s second-quarter 2026 earnings, due after the U.S. market close on August 10, will be the next major catalyst. In the first quarter, Rocket Lab posted record revenue of just over $200 million, up 63.5 percent year over year, and grew its backlog to $2.2 billion on the back of 31 new launch contracts.
That backlog and those analyst ratings sit uncomfortably alongside a stock that has lost nearly 58 percent from its 52-week high of €133.80. On a year-to-date basis, the shares are still up 37.56 percent — cold comfort for anyone who bought near the peak, but a reminder that the long-term trajectory is not entirely broken.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
What the Next Two Weeks Will Decide
With earnings still two weeks away, the near-term direction of the stock hinges on what emerges from Rocket Lab’s test stands in New Zealand. Visible progress on tank tests, stage integration, and engine qualifications could provide the kind of catalyst that macro headlines cannot. The market is effectively on watch for any signal that Neutron’s fourth-quarter 2026 target is holding — or slipping again.
For now, the stock is caught between two narratives: one in which a sector-wide rotation after the SpaceX listing has stripped away the scarcity premium from smaller space names, and another in which Rocket Lab’s own execution risk is finally being priced in. Both may be true at once. The next Neutron update will decide which one dominates.
Ad
Rocket Lab Stock: New Analysis - 26 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
